PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.33%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
3.31%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
-5.14%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-3.85%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
27.06%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
-96.10%
Other expenses reduction while VET shows 14.02% growth. Joel Greenblatt would examine efficiency.
11.28%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
6.37%
Total costs growth while VET reduces costs. John Neff would investigate differences.
12.68%
Interest expense growth while VET reduces costs. John Neff would investigate differences.
14.63%
D&A growth above 1.5x VET's 2.86%. Michael Burry would check for excessive investment.
-10.73%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-7.33%
EBITDA margin decline while VET shows 0.46% growth. Joel Greenblatt would examine position.
-21.68%
Both companies show declining income. Martin Whitman would check industry conditions.
-20.62%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-44.62%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-28.71%
Both companies show declining income. Martin Whitman would check industry conditions.
-27.75%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-19.84%
Tax expense reduction while VET shows 635.66% growth. Joel Greenblatt would examine advantage.
-31.01%
Both companies show declining income. Martin Whitman would check industry conditions.
-30.07%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-32.16%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-31.98%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
2.09%
Share count reduction below 50% of VET's 1.48%. Michael Burry would check for concerns.
1.25%
Diluted share increase while VET reduces shares. John Neff would investigate differences.